0001209191-20-038033.txt : 20200619 0001209191-20-038033.hdr.sgml : 20200619 20200619180601 ACCESSION NUMBER: 0001209191-20-038033 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200619 FILED AS OF DATE: 20200619 DATE AS OF CHANGE: 20200619 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gutch Michael CENTRAL INDEX KEY: 0001687333 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33451 FILM NUMBER: 20976807 MAIL ADDRESS: STREET 1: C/O ALBIREO PHARMA, INC. STREET 2: 50 MILK STREET, 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALBIREO PHARMA, INC. CENTRAL INDEX KEY: 0001322505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 POST OFFICE SQUARE STREET 2: SUITE 502 SOUTH CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 857-415-4774 MAIL ADDRESS: STREET 1: 10 POST OFFICE SQUARE STREET 2: SUITE 502 SOUTH CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Biodel Inc DATE OF NAME CHANGE: 20050331 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-19 0 0001322505 ALBIREO PHARMA, INC. ALBO 0001687333 Gutch Michael C/O ALBIREO PHARMA INC. 10 POST OFFICE SQUARE, SUITE 1000 BOSTON MA 02109 1 0 0 0 Stock Option (right to buy) 27.89 2020-06-19 4 A 0 8000 0.00 A 2030-06-18 Common Stock 8000 8000 D This option will vest and become exercisable in full on the earlier of (i) June 19, 2021 or (ii) the day prior to the issuer's 2021 annual meeting of stockholders, subject to the director's continued service on the issuer's board of directors on the vesting date. /s/ Jason Duncan, Attorney-in-fact 2020-06-19